
What you get
- 1× vial (product)
- 1× bacteriostatic water (2 ml)
What you need
- Syringe + needle to reconstitute (reconstitution calculator)
- Alcohol swabs
- Needle + syringe to inject
HD Labs Retatrutide 64 Vial
R3 200.00R2 900.00On sale
SKU hdreta64v
5.0(1 review)Compare & learn
HD Labs Retatrutide 64 Vial, supplied lyophilised and third-party assayed for purity and identity. Cold-chain handled and shipped discreetly from South Africa. Certificate of analysis available on request.
Please note
Prescription-class compound supplied for research use. You must be 18 or older. Consult a qualified healthcare professional before use, this is not medical advice.
Card · EFT · Discreet delivery
Complete your kit
The supplies you need to store and use your order — add yours in one tap.
BEARE Insulin Syringes 20 PackR60.00
Alcohol Swabs 50 PackR25.00
The HD Labs Retatrutide 64 Vial is a lyophilised research peptide, SKU hdreta64v, InStock at BeSkinny. It ships within South Africa only, with cold-chain handling from storage through dispatch and a gel pack for temperature integrity. See the product page for the current price.
| Attribute | Value |
|---|---|
| Product | HD Labs Retatrutide 64 Vial |
| Availability | InStock |
| SKU | hdreta64v |
| Presentation | Lyophilised |
| Payment methods | EFT, card, Bitcoin |
We stock HD Labs and Body Pharm peptides shipped nationwide via The Courier Guy and Aramex. Every batch is stated to be third-party tested for purity and identity, with a Certificate of Analysis available on the product page or on request via email. A free account is required to complete checkout. Verify the live price and stock before checkout.
HD Labs Retatrutide 64 Vial: order details
To order, create a free account at beskinny.store, add the vial to your cart, and complete payment. Orders placed and paid before 12:00 on a business day typically ship same-day. Every batch is stated to be third-party tested, with a Certificate of Analysis available on the product page or on request. For safety context, see retatrutide side effects reported in the Phase 2 trial.
Shop the full range for every compound, in the strengths that matter.
Cold-chain handling and delivery within South Africa
We ship within South Africa only. Orders placed and paid before 12:00 on a business day typically dispatch same-day; major metros usually receive delivery the next working day, while outlying areas typically take 2–5 working days. The Courier Guy and Aramex handle fulfilment, with quoted transit times of 2–7 business days depending on destination.
Every batch is stored cold-chain from receipt through dispatch. Weight-loss pens ship with a gel pack to maintain temperature integrity during transit. Lyophilised vials should be refrigerated on arrival and protected from heat and light.
Delivery terms
These are our stated fulfilment processes, not independent verification that a specific vial remained within a defined temperature range throughout transit. Actual delivery dates depend on courier capacity, weather, and address accessibility. Confirm live stock and shipping estimates at checkout before completing payment.
What "for research use" means on this page
The HD Labs Retatrutide 64 Vial is listed as a prescription-class compound supplied for research use only. This is not an approved medicine, clinical prescribing service, or medical advice.
Our product page states that buyers must be 18 or older and should consult a qualified healthcare professional before use. We do not provide dosing instructions, reconstitution guidance, or treatment protocols. The listing describes the vial as lyophilised material for laboratory research, not as a finished pharmaceutical product authorised for human administration.
Regulatory context for retatrutide
Retatrutide remains an investigational compound. ClinicalTrials.gov records from 2025–2026 describe it as a triple GIP, GLP-1 and glucagon receptor agonist still under Phase 3 development, with Eli Lilly funding the TRIUMPH programme. No SAHPRA registration for retatrutide was verified in the sources reviewed. SAHPRA's October 2025 Section 21 guidance states that unregistered medicines may only be sold under written authorisation, and that advertising or marketing of such products is prohibited.
What we can document: our batch-level Certificate of Analysis, third-party purity and identity testing claims, and cold-chain handling from storage through dispatch. What we cannot establish: that this vial matches pharmaceutical-grade material used in clinical trials, or that possession or use complies with your specific legal or professional obligations.
For deeper verification guidance, see how to verify a peptide Certificate of Analysis. For safety information from published trials, see retatrutide side effects reported in the Phase 2 trial.
